Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer-oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical knowhow of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value-based products while maintaining focus on customer needs. We have 140+ scientists working at our two R&D Centers and 4 API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities.

 

Top

Facilities

Solara / Facilities

Manufacturing Facilities

Ambernath, Maharashtra

ambernath manufacturing unit
  • Reactor Details: 250L – 8000L
  • Temperature: -20 °C to + 130 °C
  • Material of Construction: SS, GL, SS-GL, MS-GL
  • Packaging Control: Meet requirements of ISO Class – 8
  • Compliances: USFDA, EDQM
View Regulatory Inspection

Cuddalore, Tamilnadu

cuddalore-manufacturing-unit
  • Reactor Details: Size ranges from 250L to 12500L
  • Temperature: -90 °C to + 200 °C
  • Material of Construction: SS, GL, MSGL, Hastelloy
  • Packing Control: Meet requirements of ISO Class – 8
  • Compliances: USFDA, EDQM, KFDA (Korea), EU-GMP (Danish), WHO (Geneva), MHRA, Cofepris (Mexico), TGA (Australia), PMDA (Japan)
View Regulatory Inspection

Mangaluru, Karnataka

Mangalore Manufacturing Facility
  • Reactor Details: Size ranges from 250L to 6300L; Glass reactors of 20L – 250L
  • Temperature: -20 °C to + 130 °C
  • Material of Construction: SS, GL
  • Packaging Control: Meet requirements of ISO Class – 8
  • Compliances: USFDA, EDQM, KDFA (Korea), WHO (Geneva), TGA (Australia)
View Regulatory Inspection

Pondicherry

facility---pondicherry
  • Reactor Details: Range between 1200 L to 12,500 L
  • Material of Construction: SS, MSGL, GL
  • Packing Control: Meet requirements of ISO Class – 8
  • Compliances: USFDA, EDQM, AGES (Austria), KFDA (Korea), EU-GMP (Danish), MHRA, Cofepris (Mexico), PMDA (Japan)
View Regulatory Inspection

Dedicated research and development capabilities

Two India based R&D Centre for best in class product development

Chennai, R&D Center

Bangalore, R&D Center

Technical Expertise

  • Strong technical leadership to develop high-quality pharma products that create strategic value for our partners and customers

Development

  • R&D capability to develop over an entire cycle with new and better technologies at a competitive cost

Product Selection

  • Focus on differentiated products characterized by complex formulations across diverse therapeutic categories

Regulatory Filings

  • Strong IP assessment capabilities and strong global regulatory expertise
AUTHORITYAMBERNATH
USFDA2013, 2019
EDQM2017
AUTHORITYCUDDALORE
USFDA1999, 2002, 2007, 2010, 2014, 2017, 2019
EDQM2003, 2014
KFDA (Korea)2012
EU-GMP (Danish)2008
WHO (Geneva)2012, 2016
MHRA2017
Cofepris (Mexico)2013, 2014, 2015
TGA (Australia)1998
PMDA (Japan)2017
AUTHORITYMANGALORE
USFDA2012, 2015, 2018
EDQM2017
KFDA (Korea)2018
WHO (Geneva)2009, 2011, 2014, 2018
TGA (Australia)2011, 2013
AUTHORITYPONDICHERRY
USFDA1990, 1996, 2000, 2005, 2009, 2013, 2015, 2017
EDQM2007, 2014
AGES (Austria)2007
KFDA (Korea)2012, 2017
EU-GMP (Danish)2008
MHRA2017
Cofepris (Mexico)2013, 2015
PMDA (Japan)2007